[TVTX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -34.51%
YoY- 52.05%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 41,337 38,432 42,177 40,340 38,800 33,620 37,326 7.06%
PBT -22,162 -18,149 -11,038 -19,017 -15,154 -13,154 -12,288 48.32%
Tax 167 229 6,580 -1,223 -1,925 -2,064 -3,685 -
NP -22,329 -18,378 -17,618 -17,794 -13,229 -11,090 -8,603 89.19%
Tax Rate - - - - - - - -
Total Cost 63,666 56,810 59,795 58,134 52,029 44,710 45,929 24.39%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -54.02 -47.82 -41.77 -44.11 -34.10 -32.99 -23.05 76.71%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.56 -0.46 -0.45 -0.46 -0.34 -0.29 -0.23 81.27%
EPS Diluted -0.56 -0.46 -0.44 -0.46 -0.34 -0.28 -0.22 86.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.